< Back to the Blog

About the author

Amy Divaraniya
Dr. Aparna (Amy) Divaraniya is the Founder and CEO of Oova. She has over 10 years experience working in data science and a PhD in Biomedical Sciences. In 2017, Amy pivoted to women's healthcare after facing her own fertility struggles. Amy started Oova to give women control over their fertility by making high-quality hormone testing more accessible.

Sources

  1. Dumesic DA, et al. "Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome." Endocrine Reviews. 2015.
  2. Stepto NK, et al. "Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp." Human Reproduction. 2013.
  3. Lim SS, et al. "Overweight, obesity and central obesity in women with polycystic ovary syndrome." Human Reproduction Update. 2012.
  4. Moghetti P. "Insulin Resistance and Polycystic Ovary Syndrome." Current Pharmaceutical Design. 2016.
  5. Unfer V, et al. "Myo-inositol and D-chiro-inositol clinical use in assisted reproduction." Journal of Ovarian Research. 2017.
  6. Teede HJ, et al. "Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome." Human Reproduction. 2018.
  7. Escobar-Morreale HF. "Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment." Nature Reviews Endocrinology. 2018.
  8. Chang RJ. "A practical approach to the diagnosis of polycystic ovary syndrome." American Journal of Obstetrics and Gynecology. 2004.

About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.